More Articles

Generic drugmakers criticise US health plan rebates Policies & Legislation | Posted 20/10/2009

The US government could save more money by increasing the use of cheaper generic drugs rather than hiking rebates paid by manufacturers, an industry executive said on 17 September 2009.

Roche and Amgen agree on temporary Mircera import ban Policies & Legislation | Posted 20/10/2009

Roche has agreed not to oppose Amgen's request for a limited exclusion order that would block the import of Roche's anaemia drug Mircera into the US Amgen filed a motion recently with the US Intern...

Many potential buyers as sale of Ratiopharm begins Generics/News | Posted 19/10/2009

The process of divesting Ratiopharm, the world's fourth-largest generic drugmaker, owned by the conglomerate formerly run by German billionaire Mr Adolf Merckle who committed suicide at the start o...

Accenture report: biosimilars offer chances despite risks Reports | Posted 19/10/2009

According to the report Biosimilars – Emergence of a third market dynamic between original products and generics published by the global management consultancy, Accenture, the biosimilars market wi...

EU assures India to take steps to resolve drug seizure cases Policies & Legislation | Posted 19/10/2009

The EU has assured India that it will take steps to resolve the issue related to the recent cases of life-saving generic or off-patent medicines exported from India to other countries being seized...

Singapore outlines process to register biosimilars Guidelines | Posted 16/10/2009

Drugmakers seeking to register a biosimilar product in Singapore should provide complete information on the development, control and manufacture of the drug and its active ingredient, a new guidanc...

FDA approves generic prescription-only version of Plan B emergency contraceptive levonorgestrel for women ages 17 and under Generics/News | Posted 16/10/2009

The US FDA on 24 June 2009 approved the first generic version of the emergency contraceptive Plan B (levonorgestrel) tablets, 0.75 mg. The generic product will be available by prescription only for...

Will there be unfair delays for the entry of biosimilars? Biosimilars/General | Posted 15/10/2009

As pointed out by Managing Editor, Ms Maria Fabiana Jorge, in the Editorial of the Journal of Generic Medicines, Volume 6, Issue 4 of August 2009, countries around the world define the future pharm...